Neuro-Oncology Reviews
Volume
26 Number 17
20 August 2024
Home > Publications > Neuro-Oncology Reviews > Volume 26, Year 2024 > Number 17, 20 August
Hwang YK, Lee DH, Lee EC, Oh JS.
Importance
of Autophagy Regulation in Glioblastoma with Temozolomide
Resistance.
Cells.
2024 Aug 11;13(16):1332. doi:
10.3390/cells13161332. PMID:
39195222. Review. ˍ
Gawel AM, Betkowska A, Gajda E, Godlewska M, Gawel D.
Current
Non-Metal Nanoparticle-Based Therapeutic Approaches for
Glioblastoma Treatment.
Biomedicines.
2024 Aug 11;12(8):1822. doi:
10.3390/biomedicines12081822. PMID:
39200286. Review. ˍ
Huang T, Ren X, Tang X, Wang Y, Ji R, Guo Q, Ma Q, Zheng Y, Hu Z,
Zhou Y.
Current perspectives and trends
of CD39-CD73-eAdo/A2aR research in tumor microenvironment: a
bibliometric analysis.
Front
Immunol. 2024 Aug 12;15:1427380. doi:
10.3389/fimmu.2024.1427380. PMID:
39188712. Bibliometric analysis. ˍ
Lu J, Huo W, Ma Y, Wang X, Yu J.
Suppressive
immune microenvironment and CART therapy for glioblastoma: Future
prospects and challenges.
Cancer
Lett. 2024 Aug 12;600:217185. doi:
10.1016/j.canlet.2024.217185. PMID:
39142498. Review. ˍ
Ma M, Fei X, Jiang D, Chen H, Xie X, Wang Z, Huang Q.
Research
Progress on the Mechanism of Histone Deacetylases in Ferroptosis
of Glioma.
Oncol
Rev. 2024 Aug 12;18:1432131. doi:
10.3389/or.2024.1432131. PMID:
39193375. Review. ˍ
Borni M, Kammoun B, Taallah M, Mzid Y, Boudawara O, Boudawara MZ.
A case of multiples liver metastases
from a grade 2 brain meningioma: a rare entity with comprehensive
literature review.
Ann
Med Surg (Lond). 2024 Aug 14;86(9):5631-5638. doi:
10.1097/MS9.0000000000002460. PMID:
39239057. Review. ˍ
Farzad Maroufi S, Sadegh Fallahi M, Parmis Maroufi S, Sheehan JP.
Focused ultrasound blood-brain barrier
disruption in high-grade gliomas: Scoping review of clinical
studies.
J
Clin Neurosci. 2024 Aug 14;128:110786. doi:
10.1016/j.jocn.2024.110786? PMID:
39146579. Review˰ ˍ
Du L, Zhang Q, Li Y, Li T, Deng Q, Jia Y, Lei K, Kan D, Xie F,
Huang S.
Research progress on the role
of PTEN deletion or mutation in the immune microenvironment of
glioblastoma.
Front
Oncol. 2024 Aug 14;14:1409519. doi:
10.3389/fonc.2024.1409519. PMID:
39206155. Review. ˍ
Caverzan MD, Ibarra LE.
Advancing
glioblastoma treatment through iron metabolism: A focus on TfR1
and Ferroptosis innovations.
Int
J Biol Macromol. 2024 Aug 15;278(Pt 2):134777. doi:
10.1016/j.ijbiomac.2024.134777. PMID:
39153669. Review˰ ˍ
Lucchini S, Constantinou M, Marino S.
Unravelling
the mosaic: Epigenetic diversity in glioblastoma.
Mol
Oncol. 2024 Aug 15. doi:
10.1002/1878-0261.13706. PMID:
39148319. Review. ˍ
Yaman Bajin I, Bouffet E.
Advances in
the Treatment of Pediatric Low-Grade Gliomas.
Curr
Neurol Neurosci Rep. 2024 Aug 15. doi:
10.1007/s11910-024-01369-4. PMID:
39143379. Review˰ ˍ
Zarychta J, Kowalczyk A, Marszołek A, Zawitkowska J, Lejman
M.
Strategies to overcome tumor
microenvironment immunosuppressive effect on the functioning of
CAR-T cells in high-grade glioma.
Ther
Adv Med Oncol. 2024 Aug 15;16:17588359241266140. doi:
10.1177/17588359241266140. PMID:
39156126. Review. ˍ
Cini NT, Pennisi M, Genc S, Spandidos DA, Falzone L, Mitsias PD,
Tsatsakis A, Taghizadehghalehjoughi A.
Glioma
lateralization: Focus on the anatomical localization and the
distribution of molecular alterations (Review).
Oncol
Rep. 2024 Aug 16;52(4):139. doi:
10.3892/or.2024.8798. PMID:
39155859. Review. ˍ
Garcia-Moure M, Laspidea V, Gupta S, Gillard AG, Khatua S,
Parthasarathy A, He J, Lang FF, Fueyo J, Alonso MM, Gomez-Manzano
C.
The Emerging Field of
Viroimmunotherapy for Pediatric Brain Tumors.
Neuro
Oncol. 2024 Aug 16:noae160. doi:
10.1093/neuonc/noae160. PMID:
39148489. Review˰ ˍ
Grimi A, Bono BC, Lazzarin SM, Marcheselli S, Pessina F, Riva
M.
Gliomagenesis, Epileptogenesis, and
Remodeling of Neural Circuits: Relevance for Novel Treatment
Strategies in Low- and High-Grade Gliomas.
Int
J Mol Sci. 2024 Aug 16;25(16):8953. doi:
10.3390/ijms25168953. PMID:
39201639. Review. ˍ
Mehta NH, Prajapati M, Aeleti R, Kinariwala K, Ohri K, McCabe S,
Buller Z, Leskinen S, Nawabi NL, Bhatt V, Yerigeri K, Babaria V.
The Power of a Belief System: A
Systematic Qualitative Synthesis of Spiritual Care for Patients
with Brain Tumors.
J
Clin Med. 2024 Aug 18;13(16):4871. doi:
10.3390/jcm13164871. PMID:
39201013. Review. ˍ
Tsuchiya T, Kawauchi D, Ohno M, Miyakita Y, Takahashi M,
Yanagisawa S, Osawa S, Fujita S, Omura T, Narita Y.
Risk
Factors of Distant Recurrence and Dissemination of IDH
Wild-Type Glioblastoma: A Single-Center Study and Meta-Analysis.
Cancers
(Basel). 2024 Aug 18;16(16):2873. doi:
10.3390/cancers16162873. PMID:
39199644. Observational study; Meta-analysis. ˍ
*Pan J, Eskandar T, Ahmed Z, Agrawal DK.
Biophysical
and Biological Mechanisms of Tumor Treating Fields in
Glioblastoma.
J
Cancer Sci Clin Ther. 2024 Aug 19;8(3):265-270. doi:
10.26502/jcsct.5079249. PMID:
39364266. Perspective. ˍ
Habibi MA, Shad N, Mirjnani MS, Fasihi S, Sadeghi S, Karami S,
Ahmadvand MH, Delbari P, Zare AH, Zare AH, Alavi SAN.
Is
add-on Bevacizumab therapy to Temozolomide and radiotherapy
associated with clinical utility for newly diagnosed Glioblastoma?
A systematic review and meta-analysis.
Neurosurg
Rev. 2024 Aug 20;47(1):445. doi:
10.1007/s10143-024-02667-8. PMID:
39162874. Review; Meta-analysis˰
ˍ
Scalia G, Ferini G, Graziano F, Marrone S, Giurato E, Galasso MG,
Atallah O, Farooq M, Furnari M, Umana GE, Nicoletti
GF.
Intraventricular Glioblastomas: A
Systematic Review of Multimodal Treatment Strategies.
Ann
Ital Chir. 2024 Aug 20;95(4):416-434. doi:
10.62713/aic.3529. PMID:
39186332. Review. ˍ
Shah S, Lucke-Wold B.
Image-Guided
Mesenchymal Stem Cell Sodium Iodide Symporter (NIS) Radionuclide
Therapy for Glioblastoma.
Cancers
(Basel). 2024 Aug 20;16(16):2892. doi:
10.3390/cancers16162892. PMID:
39199662. Review. ˍ